This week saw a series of big-ticket funding rounds for biotech companies, with Apollo Therapeutics and Nimbus Therapeutics both pulling in upwards of $200 million, in a positive sign for private ...
As independent AI researcher Simon Willison wrote in a post distinguishing serious AI-assisted development from casual “ vibe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback